AGIO EBITDA Margin
Agios Pharmaceuticals Inc · EBITDA Margin
AGIO EBITDA Margin
Latest reported-423.84%period ending
AGIO TTM EBITDA Margin (-86.89% → -423.84%)
TTM ebitda margin
High-resolution chart · PNG
AGIO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -423.8423% | |
| -633.4136% | |
| -756.3115% | |
| -903.8936% | |
| 1,711.5009% | |
| 1,932.7987% | |
| 1,982.6347% | |
| 2,230.2851% | |
| -1,146.63% | |
| -1,178.2403% | |
| -1,287.9432% | |
| -884.6775% | |
| -1,005.8718% | |
| -1,105.1638% | |
| -1,567.6756% | |
| -3,604.8238% | |
| -5,616.5108% | |
| -42,196.6346% | |
| -771.3974% | |
| -437.5932% | |
| -301.7063% | |
| -147.4729% | |
| -161.7028% | |
| -178.5029% | |
| -202.3498% | |
| -348.878% | |
| -357.2459% | |
| -388.6739% | |
| -309.4448% | |
| -376.4364% | |
| -470.9773% | |
| -468.3093% | |
| -826.8339% | |
| -730.8874% | |
| -504.0691% | |
| -497.777% | |
| -485.3214% | |
| -279.3982% | |
| -335.4588% | |
| -313.6597% | |
| -236.4533% | |
| -195.1302% | |
| -150.9854% | |
| -61.4744% | |
| -50.0708% | |
| -80.7338% | |
| -66.6533% | |
| -176.138% | |
| -154.1945% | |
| -146.5594% | |
| -126.4251% | |
| -102.902% | |
| -93.6509% | |
| -86.8916% |